Introduction of Selectivity in Gas Sensors using Nanostructure Selection Acronym: NanoSelect

人体呼吸分析在医疗保健筛查中变得非常重要，因为它是非侵入性的，而且呼吸中含有许多可以指示患者医疗状况的化合物。迄今为止，癌症、肺部感染和糖尿病的发生都与呼吸有关。NanoSelect项目旨在为NHS等医疗服务提供者提供更简单、成本更低的呼吸分析。该项目旨在展示新型气体传感器的生产和使用，这种传感器对呼吸中可能预示疾病的挥发性化学物质更有选择性。这些化学物质被称为生物标志物，能够使用低成本分析仪在呼吸中准确检测和报告它们，将是医疗保健和患者早期治疗的重要一步。领导该项目的RoboScientific有限公司的员工拥有多年的经验和Bloodhound®商标产品系列，在医疗保健分析方面拥有出色的血统。

Human breath analysis is becoming very important in healthcare screening as it is non-invasive and breath contains many chemical compounds that can indicate the medical status of the patient. To date the presence of cancers, pulmonary infections and the onset of diabetes have all been linked to breath. The NanoSelect project is aimed at making breath analysis more simple and at less cost for healthcare providers such as the NHS. The project aims to demonstrate the production and use of new gas sensors that are more selective for the volatile chemicals in breath that can indicate disease. These chemicals are called biomarkers and being able to accurately detect and report them in breath using low cost analysers will be a significant step forward in healthcare and for the early treatment of patients. Staff of RoboScientific Ltd, the company leading the project, have many years of experience and the Bloodhound® tradmarked product range, has an excellent pedigree in healthcare analysis.